Petmed Express (PETS) EBIAT (2016 - 2025)
Petmed Express' EBIAT history spans 16 years, with the latest figure at -$10.6 million for Q4 2025.
- For Q4 2025, EBIAT fell 1392.64% year-over-year to -$10.6 million; the TTM value through Dec 2025 reached -$64.9 million, down 18270.59%, while the annual FY2025 figure was -$6.3 million, 15.98% up from the prior year.
- EBIAT reached -$10.6 million in Q4 2025 per PETS's latest filing, down from -$8.5 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $6.8 million in Q1 2021 to a low of -$34.2 million in Q2 2025.
- Average EBIAT over 5 years is -$1.8 million, with a median of $251500.0 recorded in 2022.
- The largest YoY upside for EBIAT was 430.46% in 2024 against a maximum downside of 2222.22% in 2024.
- A 5-year view of EBIAT shows it stood at $3.8 million in 2021, then tumbled by 105.55% to -$212000.0 in 2022, then crashed by 856.13% to -$2.0 million in 2023, then soared by 65.12% to -$707000.0 in 2024, then plummeted by 1392.64% to -$10.6 million in 2025.
- Per Business Quant, the three most recent readings for PETS's EBIAT are -$10.6 million (Q4 2025), -$8.5 million (Q3 2025), and -$34.2 million (Q2 2025).